2,4,6-trimethoxyamphetamine
| Structural formula | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-2,4,6-Thrimethoxy_Amphetamine.svg)
|
|||||||||||||
| ( R ) shape (left) and ( S ) shape (right) | |||||||||||||
| General | |||||||||||||
| Surname | 2,4,6-trimethoxyamphetamine | ||||||||||||
| other names |
( RS ) -1- (2,4,6-trimethoxyphenyl) -2-aminopropane |
||||||||||||
| Molecular formula | C 12 H 19 NO 3 | ||||||||||||
| External identifiers / databases | |||||||||||||
|
|||||||||||||
| properties | |||||||||||||
| Molar mass | 225.29 g mol −1 | ||||||||||||
| Physical state |
firmly |
||||||||||||
| Melting point |
214–215 ° C (as hydrochloride) |
||||||||||||
| safety instructions | |||||||||||||
|
|||||||||||||
| As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . | |||||||||||||
TMA-6 is a common name for 2,4,6-trimethoxyamphetamine , a psychedelic hallucinogen from the amphetamine structural class . It's chiral and was developed by Alexander Shulgin around 1960 .
Effect on humans
TMA-6 will usually orally ingested or nasally. In its effect, it is most likely comparable to mescaline (as well as TMA analogues such as TMA-2 ). It has both stimulating and psychedelic effects. Shulgin indicates the orally effective dose in the range of 25 to 50 mg, the duration of action is 12 to 16 hours.
Legal status
As a derivative of 2- phenethylamine , TMA-6 in Germany is subject to the New Psychoactive Substances Act that came into force in November 2016 . With the exception of the exceptions defined in the law, trading, placing on the market, manufacturing, administering and bringing TMA-6 is generally punishable.
Web links
- isomerdesign.com: TMA-6 (English)
- PIHKAL: TMA-6 (English)
Individual evidence
- ↑ a b PIHKAL: TMA-6
- ↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
